Get the most efficient and reproducible output from low sample input. Our products are designed for sequencing analysis of DNA in whole genome, whole exome, epigenetics, or amplicon applications. Swift technologies help to accelerate workflow, improve uniformity, reduce library bias, and diminish coverage gaps.
See How Swift Technology Benefits Your Application
"We are hopeful that Swift's library prep will allow us to ask more questions and get a more comprehensive view of the epigenetic changes associated with oncogenesis." - Prakash Rao, Dana Farber Cancer Institute
The Accel-Amplicon CFTR Panel offers a comprehensive approach to screen disease-relevant mutations and variants in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. This simple, rapid, and complete assay is tailored for clinical researchers and reference laboratories who discover, confirm, and screen common and rare mutations in the CFTR gene. more »
Accel-Amplicon™ CFTR Panel presented at the 2017 American College of Medical Genetics Annual Meeting – Swift Biosciences today announced the commercial release of its Accel-Amplicon CFTR Panel. This panel will offer research laboratories a more comprehensive, next-generation sequencing (NGS)-based approach to interrogate the coding region and select introns within the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) more »